Beacon Investment Advisory Services Inc. Has $814,000 Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Beacon Investment Advisory Services Inc. reduced its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 7.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 11,759 shares of the company’s stock after selling 975 shares during the period. Beacon Investment Advisory Services Inc.’s holdings in Henry Schein were worth $814,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HSIC. Cromwell Holdings LLC grew its stake in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares in the last quarter. Studio Investment Management LLC grew its position in shares of Henry Schein by 3.8% in the 3rd quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after acquiring an additional 172 shares during the period. Central Pacific Bank Trust Division increased its stake in shares of Henry Schein by 2.0% during the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock worth $706,000 after purchasing an additional 200 shares during the last quarter. Huntington National Bank raised its holdings in shares of Henry Schein by 16.8% in the 3rd quarter. Huntington National Bank now owns 1,515 shares of the company’s stock valued at $110,000 after purchasing an additional 218 shares during the period. Finally, Bridge Creek Capital Management LLC lifted its stake in Henry Schein by 0.7% in the 4th quarter. Bridge Creek Capital Management LLC now owns 38,763 shares of the company’s stock valued at $2,682,000 after purchasing an additional 260 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Henry Schein Trading Down 0.0 %

Shares of NASDAQ:HSIC opened at $74.75 on Friday. The business’s 50 day simple moving average is $72.70 and its 200 day simple moving average is $70.86. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a market capitalization of $9.32 billion, a P/E ratio of 30.76, a P/E/G ratio of 2.03 and a beta of 0.89.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period in the prior year, the firm posted $1.32 EPS. Henry Schein’s quarterly revenue was up .4% on a year-over-year basis. On average, research analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.14% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HSIC. Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Evercore ISI boosted their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Barrington Research reiterated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a report on Wednesday, November 6th. Finally, StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Seven equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $79.30.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.